HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2 + Tumors
Cancer Research - United States
doi 10.1158/0008-5472.can-16-2247
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2017
Authors
Publisher
American Association for Cancer Research (AACR)